Meritage Portfolio Management lifted its holdings in shares of CalciMedica, Inc. (NASDAQ:CALC – Free Report) by 360.0% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 46,000 shares of the company’s stock after purchasing an additional 36,000 shares during the period. Meritage Portfolio Management owned 0.81% of CalciMedica […]
/PRNewswire/ CalciMedica Inc. (CalciMedica or the Company) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium.
HC Wainwright restated their buy rating on shares of CalciMedica (NASDAQ:CALC – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a $20.00 price target on the stock. Separately, Oppenheimer reissued an outperform rating and set a $14.00 price objective on shares of CalciMedica in a report […]
Treatment with Auxora™ shown to potentially reduce the severity of asparaginase-associated pancreatitis, also called asparaginase-induced pancreatic toxicity,.